Diagnosing and treating neurological conditions often relies on subjective assessments and traditional methods, which can lead to delays in diagnosis and suboptimal treatment plans. There is a need for more objective, data-driven approaches to improve patient outcomes in neurology.

Lilia AI is developing AI-enabled medical devices to enhance the diagnosis and treatment of neurological conditions. By applying advanced data analytics and machine learning algorithms to neurological patient care, Lilia AI aims to provide clinicians with tools for more accurate and timely diagnoses. The company is initially focused on developing a novel AI brain aneurysm diagnostic technology. Lilia AI's technology aims to improve the quality of data used to train AI models, ensuring the highest quality standards for advancing patient care.

AI-driven diagnostic tools for neurological conditions

Machine learning algorithms for advanced data analytics

Focus on brain aneurysm diagnosis

Emphasis on high-quality data inputs to eliminate bias in AI models

The primary target audience includes neurologists, neurosurgeons, and other healthcare professionals involved in the diagnosis and treatment of neurological conditions.